Speaker: Katie Stage, ND, RH (AHG), FABNG Metabolic dysfunction-associated fatty liver disease (MAFLD), previously called nonalcoholic fatty liver disease (NAFLD) or simply "fatty liver", impacts at least 25% of those in North America. This session explores MAFLD including differentiating it from other conditions affecting the liver, monitoring, and treatment. An emphasis is placed on natural treatment and prevention, although pharmaceutical approaches will also be covered.
Related product: The PowerPoint for this recording is available here: 2024 Southwest Conference on Botanical Medicine: Conference Book Download (PDF)
| Accreditation Board | Credits | Type | Audience |
|---|---|---|---|
| Oregon Board of Naturopathic Medicine (OBNM) | 1.0 | General | Naturopathic Doctor (ND) |
| Oregon Board of Naturopathic Medicine (OBNM) | 0.5 | Pharmacy | Naturopathic Doctor (ND) |
| Sonoran University of Health Sciences (SUHS) | 1.0 | General | Naturopathic Doctor (ND) |
| Sonoran University of Health Sciences (SUHS) | 0.5 | Pharmacy | Naturopathic Doctor (ND) |